Please ensure Javascript is enabled for purposes of website accessibility
Neurocrine Biosciences Stock Quote

Neurocrine Biosciences (NASDAQ: NBIX)

Price as of March 27, 2023, 10:00 a.m. ET

You’re reading a free stock page from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Neurocrine Biosciences Returns vs. S&P

1 Year 5 Year 5 Year Annualized Since IPO
NBIX +3.55% +17.17% +3.22% +676%
S&P -12.45% +52.69% +8.83% +488%

Neurocrine Biosciences Company Info

Neurocrine Biosciences discovers and develops pharmaceuticals for the treatment of neurological and endocrine-related diseases.

News & Analysis

The Fool has written over 100 articles on Neurocrine Biosciences.

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 03/28/2023.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.


Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.